Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6691 AL 6705

Vesicular monoamine transport inhibitors: current uses and future directions

Rosenthal LS, Farag M, Aziz NA, Bang J.

Lancet. 2025 Aug 9;406(10503):650-664. doi: 10.1016/S0140-6736(25)01072-4.

On astrocyte-neuron interactions: Broad insights from the striatum

Khakh BS.

Neuron. 2025 Oct 1;113(19):3079-3107. doi: 10.1016/j.neuron.2025.08.009. Epub 2025 Sep 18.

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X, Song N, Xie J.

Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.

Associations Between Diabetes Mellitus and Neurodegenerative Diseases

Szablewski L.

Int J Mol Sci. 2025 Jan 10;26(2):542. doi: 10.3390/ijms26020542.

Autophagy, aging, and age-related neurodegeneration

Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, Takla M, Korolchuk VI, Rubinsztein DC.

Neuron. 2025 Jan 8;113(1):29-48. doi: 10.1016/j.neuron.2024.09.015. Epub 2024 Oct 14.

Huntington's disease clinical trials update: March 2025

Farag M, Tabrizi SJ, Wild EJ.

J Huntingtons Dis. 2025 May;14(2):191-206. doi: 10.1177/18796397251337000. Epub 2025 Apr 30.

Celiac Disease

Taylor AK, Lebwohl B, Snyder CL, Green PHR.

2008 Jul 3 [updated 2025 Dec 4]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome

Camacho J, Rioseco-Camacho N.

2012 May 31 [updated 2025 Apr 10]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Interhemispheric transcallosal approach for hemorrhagic colloid cyst

De Melo Junior JO, Landeiro JA.

Surg Neurol Int. 2025 Aug 22;16:364. doi: 10.25259/SNI_363_2025. eCollection 2025.

Von Hippel-Lindau Syndrome

van Leeuwaarde RS, Ahmad S, van Nesselrooij B, Zandee W, Giles RH.

2000 May 17 [updated 2025 May 1]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

KMT2B-Related Disorders

Abela L, Kurian MA.

2018 Apr 26 [updated 2025 May 22]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Glucose Transporter Type 1 Deficiency Syndrome

Wang D, Sands T, Tang M, Monani U, De Vivo D.

2002 Jul 30 [updated 2025 Mar 6]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Efficacy of Manual Wheelchair Skills Training for Improving Skills and Confidence in People With Hereditary Degenerative Disorders: Protocol for a Sequential Multimethods Study

Niyomwungere E, Routhier F, Gagnon C, Kirby RL, Rodrigue X, Lessard I, Lettre J, Best KL.

JMIR Res Protoc. 2025 Jul 31;14:e66974. doi: 10.2196/66974.

Huntington Disease-Like 2

Anderson DG, Krause A, Margolis RL.

2004 Jan 30 [updated 2025 Apr 10]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study

Strzelczyk A, von Podewils F, Hamer HM, Knake S, Rosenow F, Klotz KA, Kurlemann G, Melzer N, Buhleier E, Mann C, Willems LM, Zöllner JP, Gaida B, Cuny J, Bellaire D, Immisch I, Kämppi L, Brunklaus A, Schubert-Bast S.

CNS Drugs. 2025 Mar;39(3):321-331. doi: 10.1007/s40263-025-01158-8. Epub 2025 Feb 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias